A SERS-signalled, CRISPR/Cas-powered bioassay for amplification-free and anti-interference detection of SARS-CoV-2 in foods and environmental samples using a single tube-in-tube vessel
Copyright © 2023 Elsevier B.V. All rights reserved..
The pandemic of COVID-19 creates an imperative need for sensitive and portable detection of SARS-CoV-2. We devised a SERS-read, CRISPR/Cas-powered nanobioassay, termed as OVER-SARS-CoV-2 (One-Vessel Enhanced RNA test on SARS-CoV-2), which enabled supersensitive, ultrafast, accurate and portable detection of SARS-CoV-2 in a single vessel in an amplification-free and anti-interference manner. The SERS nanoprobes were constructed by conjugating gold nanoparticles with Raman reporting molecular and single-stranded DNA (ssDNA) probes, whose aggregation-to-dispersion changes can be finely tuned by target-activated Cas12a though trans-cleavage of linker ssDNA. As such, the nucleic acid signals could be dexterously converted and amplified to SERS signals. By customizing an ingenious vessel, the steps of RNA reverse transcription, Cas12a trans-cleavage and SERS nanoprobes crosslinking can be integrated into a single and disposal vessel. It was proved that our proposed nanobioassay was able to detect SARS-CoV-2 as low as 200 copies/mL without any pre-amplification within 45 min. In addition, the proposed nanobioassay was confirmed by clinical swab samples and challenged for SARS-CoV-2 detection in simulated complex environmental and food samples. This work enriches the arsenal of CRISPR-based diagnostics (CRISPR-Dx) and provides a novel and robust platform for SARS-CoV-2 decentralized detection, which can be put into practice in the near future.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:452 |
---|---|
Enthalten in: |
Journal of hazardous materials - 452(2023) vom: 15. Juni, Seite 131195 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ma, Long [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 01.05.2023 Date Revised 22.05.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.jhazmat.2023.131195 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM354683276 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM354683276 | ||
003 | DE-627 | ||
005 | 20231226062737.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jhazmat.2023.131195 |2 doi | |
028 | 5 | 2 | |a pubmed24n1182.xml |
035 | |a (DE-627)NLM354683276 | ||
035 | |a (NLM)36963196 | ||
035 | |a (PII)S0304-3894(23)00477-6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ma, Long |e verfasserin |4 aut | |
245 | 1 | 2 | |a A SERS-signalled, CRISPR/Cas-powered bioassay for amplification-free and anti-interference detection of SARS-CoV-2 in foods and environmental samples using a single tube-in-tube vessel |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.05.2023 | ||
500 | |a Date Revised 22.05.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 Elsevier B.V. All rights reserved. | ||
520 | |a The pandemic of COVID-19 creates an imperative need for sensitive and portable detection of SARS-CoV-2. We devised a SERS-read, CRISPR/Cas-powered nanobioassay, termed as OVER-SARS-CoV-2 (One-Vessel Enhanced RNA test on SARS-CoV-2), which enabled supersensitive, ultrafast, accurate and portable detection of SARS-CoV-2 in a single vessel in an amplification-free and anti-interference manner. The SERS nanoprobes were constructed by conjugating gold nanoparticles with Raman reporting molecular and single-stranded DNA (ssDNA) probes, whose aggregation-to-dispersion changes can be finely tuned by target-activated Cas12a though trans-cleavage of linker ssDNA. As such, the nucleic acid signals could be dexterously converted and amplified to SERS signals. By customizing an ingenious vessel, the steps of RNA reverse transcription, Cas12a trans-cleavage and SERS nanoprobes crosslinking can be integrated into a single and disposal vessel. It was proved that our proposed nanobioassay was able to detect SARS-CoV-2 as low as 200 copies/mL without any pre-amplification within 45 min. In addition, the proposed nanobioassay was confirmed by clinical swab samples and challenged for SARS-CoV-2 detection in simulated complex environmental and food samples. This work enriches the arsenal of CRISPR-based diagnostics (CRISPR-Dx) and provides a novel and robust platform for SARS-CoV-2 decentralized detection, which can be put into practice in the near future | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Amplification-free | |
650 | 4 | |a CRISPR-Dx | |
650 | 4 | |a Clinical and contaminated food samples | |
650 | 4 | |a One-vessel detection | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a Surface-enhanced Raman scattering | |
650 | 7 | |a Gold |2 NLM | |
650 | 7 | |a 7440-57-5 |2 NLM | |
650 | 7 | |a RNA |2 NLM | |
650 | 7 | |a 63231-63-0 |2 NLM | |
700 | 1 | |a Zhang, Wenlu |e verfasserin |4 aut | |
700 | 1 | |a Yin, Lijuan |e verfasserin |4 aut | |
700 | 1 | |a Li, Yaru |e verfasserin |4 aut | |
700 | 1 | |a Zhuang, Jianwen |e verfasserin |4 aut | |
700 | 1 | |a Shen, Liang |e verfasserin |4 aut | |
700 | 1 | |a Man, Shuli |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of hazardous materials |d 1998 |g 452(2023) vom: 15. Juni, Seite 131195 |w (DE-627)NLM093662688 |x 1873-3336 |7 nnns |
773 | 1 | 8 | |g volume:452 |g year:2023 |g day:15 |g month:06 |g pages:131195 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jhazmat.2023.131195 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 452 |j 2023 |b 15 |c 06 |h 131195 |